Moutzouri Elisavet, Beglinger Shanthi, Feller Martin, Eichenberger Anne, Dalleur Olivia, Knol Wilma, Emmelot-Vonk Marielle, O'Mahony Denis, Boland Benoit, Aubert Carole E, Chocano-Bedoya Patricia O, Aujesky Drahomir, Spinewine Anne, Rodondi Nicolas
Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
BMC Geriatr. 2025 Jul 19;25(1):541. doi: 10.1186/s12877-025-06189-w.
The prevalence of vitamin D supplementation and the percentage of participants with a lack of appropriate vitamin D supplementation ("potential underuse") or potentially inappropriate vitamin D supplementation ("potential overuse") and risk factors for these are currently unclear.
Cross-sectional analysis from the OPERAM study, a multicenter cluster randomized controlled trial in four European countries (Belgium, Ireland, The Netherlands, Switzerland) including multimorbid (≥ 3 chronic conditions) older patients, with polypharmacy (≥ 5 chronic medications). For the definition of potential underuse and overuse we used high-risk conditions, which were defined according to the START criteria (version 2) for potential prescribing omissions in older people i.e., E2) long-term systemic corticosteroid therapy, known osteoporosis or osteopenia, E3) previous fragility fractures, and E5) housebound/in nursing homes or experiencing falls. We used mixed effect logistic regression to identify factors associated with underuse and overuse.
2008 patients (79.4y, SD 6.3, 45% female) were included. 825/2008 (41.1%) were supplemented with vitamin D. We identified 681 participants with potential underuse (33.9% of all participants, 69.7% of non-vitamin D users) and 204 with potential overuse (10.2% of all participants, 24.7% of vitamin D users). In the multivariable logistic regression analysis increasing age and being male were associated with underuse, while the number of baseline medications and previous hospitalizations were associated with both underuse and overuse. Specifically, underuse decreased with an increasing number of medications (OR: 0.93, 95% CI: 0.90-0.95), while overuse increased (OR: 1.08, 95% CI: 1.04-1.12). Previous hospitalizations were linked to underuse (OR: 1.08, 95% CI: 1.00-1.17) and inversely associated with overuse (OR: 0.88, 95% CI: 0.77-0.99).
One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.
NCT02986425, Registration date 2016-10-21.
目前尚不清楚维生素D补充剂的使用情况,以及缺乏适当维生素D补充(“潜在未充分使用”)或可能不适当的维生素D补充(“潜在过度使用”)的参与者比例及其风险因素。
来自OPERAM研究的横断面分析,这是一项在四个欧洲国家(比利时、爱尔兰、荷兰、瑞士)进行的多中心整群随机对照试验,纳入患有多种疾病(≥3种慢性病)的老年患者,且服用多种药物(≥5种慢性药物)。对于潜在未充分使用和过度使用的定义,我们采用了高风险条件,这些条件是根据老年人潜在处方遗漏的START标准(第2版)定义的,即E2)长期全身皮质类固醇治疗、已知的骨质疏松症或骨质减少症、E3)既往脆性骨折,以及E5)居家/养老院居住或有跌倒经历。我们使用混合效应逻辑回归来确定与未充分使用和过度使用相关的因素。
纳入2008例患者(79.4岁,标准差6.3,45%为女性)。825/2008(41.1%)接受了维生素D补充。我们确定681例参与者存在潜在未充分使用(占所有参与者的33.9%,非维生素D使用者的69.7%),204例存在潜在过度使用(占所有参与者的10.2%,维生素D使用者的24.7%)。在多变量逻辑回归分析中,年龄增加和男性与未充分使用相关,而基线用药数量和既往住院与未充分使用和过度使用均相关。具体而言,未充分使用随着用药数量的增加而减少(比值比:0.93,95%置信区间:0.90 - 0.95),而过度使用增加(比值比:1.08,95%置信区间:1.04 - 1.12)。既往住院与未充分使用相关(比值比:1.08,95%置信区间:1.00 - 1.17),与过度使用呈负相关(比值比:0.88,95%置信区间:0.77 - 0.99)。
三分之一患有多种疾病的老年人存在潜在未充分使用维生素D的情况,而高达10%的人存在潜在过度使用维生素D补充剂的情况。多种药物治疗、既往住院、年龄增加和男性是与维生素D使用不当相关的因素。有必要进行更有针对性的维生素D补充。
NCT02986425,注册日期2016年10月21日。